112 related articles for article (PubMed ID: 3768491)
1. Inhibition of tumor cell growth in vitro and in vivo by 2-methyl 9-hydroxyellipticinium entrapped within phospholipid vesicles.
Sautereau AM; Cros S; Tocanne JF
Biopharm Drug Dispos; 1986; 7(4):357-71. PubMed ID: 3768491
[TBL] [Abstract][Full Text] [Related]
2. Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemia.
Paoletti C; Cros S; Xuong ND; Lecointe P; Moisand A
Chem Biol Interact; 1979 Apr; 25(1):45-58. PubMed ID: 466727
[TBL] [Abstract][Full Text] [Related]
3. [2 new antineoplastic derivatives: 9-hydroxy-2-methyl-ellipticinium (acetate) and 9-hydroxy-2,6-dimethyl-ellipticinium (chloride). Effect on mouse L 1210 leukemia].
Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Paoletti C
C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(18):1365-7. PubMed ID: 815025
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
Brassinne C; Atassi G; Frühling J; Penasse W; Coune A; Hildebrand J; Ruysschaert JM; Laduron C
J Natl Cancer Inst; 1983 Jun; 70(6):1081-6. PubMed ID: 6574278
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic efficacy of Nocodazole encapsulated in liposomes on L1210 murine leukemia.
Laduron C; Coune A; Atassi G; Hildebrand J; Ruysschaert JM; Stryckmans P; Brassinne C
Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):419-36. PubMed ID: 6190203
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia.
Lidereau R; Chermann JC; Gruest J; Montagnier L; Ducrocq C; Rivalle C; Bisagni E
Bull Cancer; 1980; 67(1):1-8. PubMed ID: 7362880
[TBL] [Abstract][Full Text] [Related]
7. Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitro.
Samadi-Baboli M; Favre G; Blancy E; Soula G
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):233-41. PubMed ID: 2702978
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
[TBL] [Abstract][Full Text] [Related]
9. Toxicity and antitumor activity of cis-bis-cyclopentenecarboxylato-1,2-diaminocyclohexane platinum(II) encapsulated in multilamellar vesicles.
Perez-Soler R; Khokhar AR; Hacker MP; Lopez-Berestein G
Cancer Res; 1986 Dec; 46(12 Pt 1):6269-73. PubMed ID: 3779646
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activity of pyranocarbazole analogues of ellipticine and acronycine.
Tran-Thi HA; Nguyen-Thi T; Michel S; Tillequin F; Koch M; Pfeiffer B; Pierré A; Trinh-Van-Dufat H
Chem Pharm Bull (Tokyo); 2004 May; 52(5):540-5. PubMed ID: 15133204
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles.
Mayhew E; Papahadjopoulos D; Rustum YM; Dave C
Cancer Res; 1976 Dec; 36(12):4406-11. PubMed ID: 187321
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antitumoral activity of free, and encapsulated taxol.
Bartoli MH; Boitard M; Fessi H; Beriel H; Devissaguet JP; Picot F; Puisieux F
J Microencapsul; 1990; 7(2):191-7. PubMed ID: 1970357
[TBL] [Abstract][Full Text] [Related]
13. Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.
Mayer LD; Nayar R; Thies RL; Boman NL; Cullis PR; Bally MB
Cancer Chemother Pharmacol; 1993; 33(1):17-24. PubMed ID: 8269584
[TBL] [Abstract][Full Text] [Related]
14. Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
Auclair C; Voisin E; Banoun H; Paoletti C; Bernadou J; Meunier B
J Med Chem; 1984 Sep; 27(9):1161-6. PubMed ID: 6471070
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
Sorace RA; Sheid B
Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
[No Abstract] [Full Text] [Related]
16. Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).
Paoletti C; Le Pecq JB; Dat-Xuong N; Juret P; Garnier H; Amiel JL; Rouesse J
Recent Results Cancer Res; 1980; 74():107-23. PubMed ID: 7003658
[TBL] [Abstract][Full Text] [Related]
17. Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells.
Esnault C; Roques BP; Jacquemin-Sablon A; Le Pecq JB
Cancer Res; 1984 Oct; 44(10):4355-60. PubMed ID: 6467197
[TBL] [Abstract][Full Text] [Related]
18. Effects of the 6-alkyl substitution of ellipticine on the uptake by NIH-3T3 cells and on the cytotoxicity.
Deprés JP; Larue L; Paoletti J; Gouyette A
Anticancer Res; 1988; 8(1):191-6. PubMed ID: 3358635
[TBL] [Abstract][Full Text] [Related]
19. omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
Bernadou J; Meunier G; Paoletti C; Meunier B
J Med Chem; 1983 Apr; 26(4):574-9. PubMed ID: 6834391
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.
Ganapathi R; Krishan A; Wodinsky I; Zubrod CG; Lesko LJ
Cancer Res; 1980 Mar; 40(3):630-3. PubMed ID: 7471083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
